Back to POLEN CAPITAL MANAGEMENT LLC POLEN CAPITAL MANAGEMENT LLC

ABTABT
Showing 8 of 28 quarters

Position history for POLEN CAPITAL MANAGEMENT LLCPOLEN CAPITAL MANAGEMENT LLC's holdings in ABBOTT LABORATORIES

POLEN CAPITAL MANAGEMENT LLC holds 3,156 shares of ABT (ABBOTT LABORATORIES), worth $286,379 as of 2026-Q2. The position was decreased (-79.1% shares). ABT represents 0.0% of POLEN CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$286,379

Current Shares

3,156

Total Value Change

-$1.6B

Total Shares Change

-13.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3,156
-79.1%
$286,3790.0%$90.10
0
2026-Q1
Decreased
15,081
-99.6%
$1.5M0.0%$101.31
0
2025-Q4
Decreased
4M
-46.6%
$496.4M2.1%$123.00
0
2025-Q3
Decreased
7.4M
-30.4%
$993.9M3.2%$130.91
0
2025-Q2
Decreased
10.7M
-6.3%
$1.5B4.5%$132.34
0
2025-Q1
Decreased
11.4M
-10.3%
$1.5B4.7%$128.48
0
2024-Q4
Decreased
12.7M
-9.0%
$1.4B3.9%$108.98
0
2024-Q3
Decreased
13.9M
-8.9%
$1.6B4.1%$109.33
0

Other major holders of ABT: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used